BRISTOL MYERS SQUIBB
- Country
- ๐ซ๐ทFrance
- Ownership
- -
- Established
- 1989-01-01
- Employees
- 30K
- Market Cap
- $97.5B
- Website
- https://www.bms.com/
A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-04-25
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT00002207
- Locations
- ๐บ๐ธ
ID Care Inc, Somerville, New Jersey, United States
๐บ๐ธFanno Creek Clinic, Portland, Oregon, United States
๐บ๐ธDr Iraj Mirshahi, Richmond, Virginia, United States
A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-04-14
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT00002176
- Locations
- ๐บ๐ธ
Univ of California at San Francisco Gen Hosp, San Francisco, California, United States
A Study Comparing Two Forms of Didanosine in HIV-infected Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-04-14
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 30
- Registration Number
- NCT00002360
A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-04-14
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT00002177
- Locations
- ๐บ๐ธ
Univ of California at San Francisco Gen Hosp, San Francisco, California, United States
Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-08-05
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 300
- Registration Number
- NCT00002035
- Locations
- ๐บ๐ธ
AIDS Research Consortium of Atlanta, Atlanta, Georgia, United States
๐บ๐ธAlbany Med College / AIDS Treatment Ctr, Albany, New York, United States
๐บ๐ธUniv of Texas Southwestern Med Ctr of Dallas, Dallas, Texas, United States
A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-05-04
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT00013897
- Locations
- ๐บ๐ธ
Associates in Research, Fort Myers, Florida, United States
๐บ๐ธThe CORE Ctr, Chicago, Illinois, United States
๐บ๐ธOhio State Univ Hosp, Columbus, Ohio, United States
A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2007-10-02
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT00002274
- Locations
- ๐บ๐ธ
Bristol - Myers Squibb Co, Princeton, New Jersey, United States
Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2007-10-02
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT00002057
- Locations
- ๐บ๐ธ
Birmingham Veterans Administration Med Ctr / Univ of Alabama, Birmingham, Alabama, United States
๐บ๐ธBristol - Myers Squibb Co, Princeton, New Jersey, United States
A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2007-10-02
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT00002358
- Locations
- ๐บ๐ธ
Bristol - Myers Squibb Co, Wallingford, Connecticut, United States
A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2007-10-02
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 200
- Registration Number
- NCT00002369
- Locations
- ๐ต๐ท
San Juan AIDS Program, Santurce, Puerto Rico
๐บ๐ธBoston Univ Med Ctr Hosp / Evans - 556, Boston, Massachusetts, United States
๐บ๐ธHIV Clinical Research Ctr, Fort Lauderdale, Florida, United States